Answers are grounded in this paper and cite their sources.
This Viewpoint assesses the affordability of traditional Medicare and Medicare Advantage Part D prescription drug benefits in the context of changes by the Inflation Reduction Act.
No takes yet. Share an insight, caveat, or question.
Stacie B. Dusetzina (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: